Rare diseases
Investigational molecules
Locations
Back to Latvia9 clinical trials in Adazi, Latvia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in LatviaKliniskiePetijumi.lv(opens in a new tab)Study of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease
LatviaPhase 3 Randomized Placebo‑Controlled Study of Efgartigimod Alfa in Adults with Graves’ Disease Inadequately Controlled by Antithyroid Drugs
LatviaA study to evaluate the long-term safety and effectiveness of sonelokimab in patients with psoriatic arthritis
LatviaStudy of sonelokimab injection in adults with active psoriatic arthritis who have not received biological DMARDs treatment before
LatviaStudy on the Effects and Safety of Guselkumab for Patients with Active Psoriatic Arthritis
LatviaStudy of Risankizumab vs. Placebo for Patients with Active Psoriatic Arthritis and Inadequate Response to DMARD Therapy
LatviaStudy Comparing Upadacitinib, Placebo, and Adalimumab for Patients with Moderate to Severe Rheumatoid Arthritis on Stable Methotrexate Treatment
LatviaStudy on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults
LatviaStudy on the Effects of Upadacitinib in Adults with Moderate to Severe Systemic Lupus Erythematosus (SLE)
LatviaThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on psoriatic arthritis and rheumatoid arthritis, evaluating novel therapeutic approaches for patients with moderate to severe symptoms.
Multiple trials are investigating new biologics and comparing their effectiveness to existing treatments.
Comprehensive research into Systemic Lupus Erythematosus, examining long-term treatment options and innovative therapies for moderate to severe cases.
Studies focus on both immediate symptom relief and sustained disease management outcomes.
Advanced clinical research evaluating immunomodulatory treatments for various inflammatory conditions, with emphasis on patient response and safety profiles.
Trials are designed to assess both rapid symptom relief and long-term disease control.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
